StageSeed VC | Alive
Developer of products for clinical testing, therapies, devices, and other life science products. The company, a joint venture between life science contract manufacturer Incell and Wisetree Invest, aims to accelerate the development and manufacturing of regenerative and personalized medicine products for clinical testing, therapies, devices, and other life science products and services, using Incell’s manufacturing technology, and to create spin-out companies of them.
Missing: BioTurnKey's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: BioTurnKey's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
BioTurnKey Frequently Asked Questions (FAQ)
Where is BioTurnKey's headquarters?
BioTurnKey's headquarters is located at Novalis Science Park, Aye.
What is BioTurnKey's latest funding round?
BioTurnKey's latest funding round is Seed VC.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.